Panelists discuss the growing role of continuous infusion therapies in managing advanced Parkinson disease, highlighting their effectiveness in reducing motor fluctuations and dyskinesia, improving quality of life, and supporting individualized, long-term treatment strategies amid ongoing advancements in drug delivery and patient selection.
Panelists discuss the growing role of continuous infusion therapies in managing advanced Parkinson disease, highlighting their effectiveness in reducing motor fluctuations and dyskinesia, improving quality of life, and supporting individualized, long-term treatment strategies amid ongoing advancements in drug delivery and patient selection.
Experts on spasticity provide advice for practicing clinicians to optimize patient outcomes.
Experts on spasticity explore real-world outcomes and treatment trends in the disease treatment landscape.
Experts on spasticity discuss the potential use of ITB pumps earlier in therapy to optimize patient outcomes.
Experts on spasticity outline the practical considerations in using ITB therapy, including access, risks, and pump malfunctions.
Experts on spasticity discuss how patients do with ITB over the long term, highlighting replacement and discontinuation data from the Product Surveillance Registry.
Key opinion leaders continue a conversation around ITB pumps in spasticity management.
A panel of experts discuss optimal candidacy considerations for intrathecal baclofen ITB pumps.
A panel of experts discuss safety concerns with intrathecal baclofen ITB pumps.
A panel of experts discuss how intrathecal baclofen ITB pumps have changed over time.
A panel of experts discuss ITB use in spasticity treatment.
A panel of experts discuss available options for treatment of severe spasticity.
A panel of experts discuss designing treatment plans based on patient goals.
A panel of experts discuss treatment options available for spasticity as well as when patients should be treated with pharmacological options.
A panel of experts discuss variation in spasticity between patients and the role disease severity can play.
Key opinion leaders examine the short-term and long-term effects of spasticity on patients' and caregivers' quality of life.
The expert panel examines the evolution of moderate to severe spasticity following injury or insult, focusing on alterations in joint mobility, changes in range of motion from early to later stages, and other progressive manifestations of the condition.
Khashayar Dashtipour, MD, PhD; Francois Bethoux, MD; Jennifer Smith, PA, and Ye Vivian Liang, MD, PhD offer a comprehensive examination of the underlying mechanisms and physiological processes involved in spasticity.
Published: July 10th 2024 | Updated:
